On April 12, 2022, ASCO announced the establishment of the ASCO Center for Equity, Diversity, and Inclusion, which will advance the Society’s equity, diversity, and inclusion (EDI) goals across the organization and throughout the wider oncology community. ASCO Chief Equity, Diversity, and Inclusion Officer Sybil Green, JD, RPh, MHA, will serve as the Center’s Inaugural Vice President, with lead responsibility for guiding and organizing the organization’s far-reaching external and internal EDI efforts.
Sybil Green, JD, RPh, MHA
Clifford A. Hudis, MD, FACP, FASCO
“The launch of the new Center for Equity, Diversity, and Inclusion signals ASCO’s commitment and focus on creating and sustaining meaningful change that translates into high-quality, equitable cancer care for all individuals with cancer,” said ASCO Chief Executive Officer Clifford A. Hudis, MD, FACP, FASCO. “This formative step builds on ASCO’s long-standing commitment to health equity by placing this critical resource in the heart of ASCO’s organizational structure.”
Infusing Equity Into All Activities
This announcement follows the recent release of the ASCO Equity, Diversity, and Inclusion Plan, which aims to infuse equity into all of the organization’s activities. Organized around ASCO’s mission pillars of research, education, and quality, the ASCO EDI Action Plan describes the three overarching goals ASCO intends to achieve:
In addition to the tireless efforts and steadfast dedication of a large number of ASCO volunteers who have helped guide these efforts, the ASCO EDI Staff Advisory Council—consisting of ASCO staff members from every department—has contributed countless hours to ensuring that ASCO has an inclusive culture where everyone feels informed, connected, and valued, and all workforce members have opportunities to achieve their potential.
“I’m deeply honored to be a part of ASCO’s work in this area and am deeply grateful for the many ASCO volunteers and staff who have provided expertise and guidance along the way,” said Ms. Green. “Our work is far from over, but we have a clear roadmap to support our progress and ensure our own accountability. Long-term success will depend on a dedicated, consistent, and ongoing effort from ASCO and this new Center is evidence of just that.”
From its inception, ASCO has been committed to addressing health disparities in cancer care and has published multiple statements and guidance to highlight specific areas of concern and efforts needed to address cancer equity. ASCO has issued recommendations on reducing disparities in cancer care, reducing disparities through the Affordable Care Act, charting the future of cancer health disparities research, and improving diversity in clinical trial participation. In 2020, reflecting its long-standing commitment to health equity, ASCO updated its mission statement to read: “Conquering cancer through research, education, and promotion of the highest quality, equitable patient care.”
For an illustrated overview of ASCO’s Equity, Diversity, and Inclusion Action Plan and to learn more about all of ASCO’s equity-related activities, visit asco.org/equity.
ASCO’s EDI work is funded by donations to EDI Initiatives through Conquer Cancer®, the ASCO Foundation.